Stanford University’s new Gastrointestinal Pain Program is showing how efficient communication between Gastroenterologists & Pain Management specialists can lead to better results for patients.
It’s all too often that patients with chronic conditions find themselves in the position of treatment manager, coordinating communications between their general practitioner & the multiple specialists they may have to see. Patients in this situation will often feel lost in a sea of doctors appointments, ensuring tests & medical records get transferred properly as well as researching & managing their own illness. Those patients may also feel as though no one in the medical community is really taking a lead in ensuring their wellbeing as often doctors who don’t work within the same medical practice(or even those who do) are distant, with communication not being their strong suit. Continue reading “Communication Key To Managing Gastrointestinal Pain” »
After relatively successful Phase III trials Ironwood Pharmaceuticals’ has applied for final FDA approval of their flagship drug, Linaclotide, which is for the treatment of constipation & pain related Irritable Bowel Syndrome symptoms.
Continue reading “Ironwood Pharmaceuticals’ Linaclotide IBS Drug Looking For Final FDA Approval” »
The Independant, a Santa Barbara based paper, has an interview with Ben Morrison, a comedian who has dealt with Crohn’s Disease since 1997.
… But for comedian Ben Morrison, who was hit with a Crohn’s disease diagnosis during his senior year of high school about a decade ago, finding humor in his situation has been the only way to stay positive and even keep the little known intestinal woe under control. He’ll be bringing his Crohn’s-related stand-up show “Pain in the Butt” to town this weekend, and he spent a few minutes chatting with The Independent last month.
Read the rest of the interview @ The Independant’s website.
You can also check out Ben Morrison’s website.
Kirsten Tillisch a doctor of medicine at the University of California in Los Angeles, along with her colleagues recently published the results of their meta-analysis on brain activity studies for patients with Irritable Bowel Syndrome. While reviewing these past studies they found that the brains of patients with Irritable Bowel Syndrome were more likely to experience activity in emotional arousal sectors(pregenual anterior cingulate cortex, amygdala) and endogenous pain modulation sector(midbrain cluster). The overall results of the analysis “support[s] a role for central nervous system dysregulation in IBS.” Continue reading “Irritable Bowel Syndrome Causes Emotion & Pain Sensitivity To Increase” »